帝京大学医学部附属病院は、東京都板橋区に所在する医療機関。学校法人帝京大学により運営される病院である。帝京大学医学部、薬学部、医療技術学部がある帝京大学板橋キャンパスにあり、特定機能病院の承認を受ける。

During the past decade, Teikyo University Hospital conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 20 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 17 clinical trials were completed. i.e. 77.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Teikyo University Hospital" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Abbott Medical Devices" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Teikyo University Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Boston Scientific Japan K.K." with 1 trials as a collaborator and "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Teikyo University Hospital" are "Coronary Artery Disease" (10 trials), "Psoriasis" (7 trials), "Palmoplantar Pustulosis" (3 trials), "ALS" (2 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "Teikyo University Hospital" in a lesser frequency.

Most popular intervention types in "Teikyo University Hospital" are "Drug" (36 trials), "Device" (11 trials), "Other" (4 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Apremilast" (3 trials), "Aspirin" (3 trials), "BMS-986165" (3 trials) and "Etrasimod" (2 trials). Other intervention names were less common.

The vast majority of trials in "Teikyo University Hospital" are 49 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Teikyo University Hospital". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Teikyo University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Teikyo University Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".